(Press-News.org) Researchers at the Francis Crick Institute and AlveoliX have developed the first human ‘lung-on-chip’ model using stem cells taken from only one person.
These chips simulate breathing motions and lung disease in an individual, holding promise for testing treatments for infections like tuberculosis (TB) and delivering personalised medicine.
Air sacs in the lungs called alveoli are the essential site of gas exchange and also an important barrier against inhaled viruses and bacteria that cause respiratory diseases like flu or TB.
Researchers have been working to recreate the battle between human cells and bacteria in the lab by building a ‘lung-on-a-chip’: small units of human lung on a plastic chip containing tiny channels and compartments. In this case, they aimed to recreate air sacs to understand how they respond to infection.
Until now, these ‘lung-on-chip’ devices have been made of a mixture of patient-derived and commercially available cells, meaning they can’t fully replicate the lung function or disease progression of a single individual.
In a study published today in Science Advances, the team at the Crick developed a new lung-on-chip model that contains only genetically identical cells derived from stem cells from a single donor.
Based on a protocol developed previously by the lab, the team produced type I and II alveolar epithelial cells and vascular endothelial cells from human-induced pluripotent stem cells, cells that can virtually become any cell in the body. These epithelial and endothelial cells are separately grown on the top and bottom of a very thin membrane in a device manufactured by biotechnology company AlveoliX to recreate an air sac barrier.
To further simulate the human lung, AlveoliX has designed specialised machines to impose rhythmic three-dimensional stretching forces on the recreated air sac barrier, mimicking the motion of breathing. This stimulates the formation of microvilli, a key feature of alveolar epithelial cells to increase surface area for lung functions (image).
Next, the scientists added immune cells called macrophages into the chip, again produced from the stem cells of the same donor, before adding TB bacteria to simulate the early stages of the disease.
In the chips infected with TB, the team reported large macrophage clusters containing ‘necrotic cores’, a group of dead macrophages in the centre, surrounded by live macrophages. Eventually, five days after infection, the endothelial and epithelial cell barriers collapsed, showing that the air sac function had broken down.
Max Gutierrez, Principal Group Leader of the Host-Pathogen Interactions in Tuberculosis Laboratory at the Crick and senior author, said: “Given the increasing need for non-animal technologies, organ-on-chip approaches are becoming ever more important to recreate human systems, avoiding differences in lung anatomy, makeup of immune cells and disease development between animals and humans.
“Composed of entirely genetically identical cells, the chips could be built from stem cells from people with particular genetic mutations. This would allow us to understand how infections like TB will impact an individual and test the effectiveness of treatments like antibiotics.”
Jakson Luk, Postdoctoral Fellow in the Host-Pathogen Interactions in Tuberculosis Laboratory and first author, said: “TB is a slow-moving disease, with months between infection and the development of symptoms, so there’s an increasing need to understand what’s happening in the unseen early stages.
“We were successfully able to mimic these initial events in TB progression, giving a holistic picture of how different lung cells respond to infections. We’re excited that the new model could be applied to a huge range of research, such as other respiratory infections or lung cancer, and we’re now looking at refining the chip by incorporating other important cell types.”
-ENDS-
For further information, contact: press@crick.ac.uk or +44 (0)20 3796 5252
Notes to Editors
Reference: Luk, C. et al. (2025). Autologous human iPSC-derived Alveolus-on-Chip reveals early pathological events of M. tuberculosis infection. Science Advances. 10.1126/sciadv.aea9874.
The Francis Crick Institute is a biomedical discovery institute with the mission of understanding the fundamental biology underlying health and disease. Its work helps improve our understanding of why disease develops which promotes discoveries into new ways to prevent, diagnose and treat disease.
An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London.
The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe.
http://crick.ac.uk/
END
How people moved pigs across the Pacific
Genomic study reveals the routes taken by people as they island hopped across Indonesia
A new study, published today in the journal Science, reveals how millennia of human migration across Pacific islands led to the introduction of invasive pig species all over the Asia-Pacific region.
The study was led by Laurent Frantz, Professor of Palaeogenomics at Queen Mary University of London (QMUL), and the Ludwig Maximilians University of Munich (LMU), David Stanton, from Cardiff University, and Greger Larson, from the University of Oxford.
Plants and animals have not always spread ...
The Qinghai-Tibet plateau (QTP) is the largest and highest plateau in the world, and is an important center for biodiversity that houses an array of high-elevation ecosystems. Despite its importance, QTP has faced multiple conservation challenges over the past decades, in particular due to climate changes (e.g. rising temperature, changing precipitation patterns, and an increase in extreme weather) and over exploitation of natural resources by human activities. Despite growing evidence that plant diversity on QTP ...
As global uncertainty intensifies, governments around the world are grappling with how to make decisions that safeguard long-term stability while remaining adaptable to sudden change. In a newly published interview in the journal Risk Sciences, Lim Siong Guan—one of Singapore’s most experienced public-sector leaders—offers a rare, first-hand perspective on how uncertainty can be managed through governance, leadership, and culture.
Lim emphasizes that effective governance is not about eliminating risk, but about anticipating the future and building resilience. ...
Large language models (LLMs), such as ChatGPT, have rapidly entered healthcare, but strong clinical evidence for their real-world use remains limited. A new study published in Gastroenterology & Endoscopy provides the first overview of randomized controlled trials (RCTs) evaluating LLMs specifically in digestive diseases.
The international research team systematically reviewed published and ongoing RCTs conducted since 2022 and identified only 14 eligible trials worldwide—four published and ten ongoing. Most studies ...
In autonomous driving, robotics, and augmented reality, accurate localization remains one of the most challenging problems. Traditional visual–inertial odometry systems often struggle with environmental variations, sensor noise, and multi-modal information fusion, limiting applications such as autonomous vehicles navigating complex urban environments and drones operating in GPS-denied areas.
In a study published in the journal iOptics, a research team from Chongqing University of Posts and Telecommunications proposed a modality fusion strategy—visual–inertial cross-modal interaction and selection mechanisms. This approach not only improves ...
Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) effectively at boost the immune system; however, they may cause immune-related adverse events (irAEs). The predictive biomarkers and risk factors for irAEs have not been determined. Further, while activated T-cell infiltration of tissues is a hallmark of irAEs, it remains unclear if this is a prerequisite for irAEs development or merely a consequence.
To that end, a team of researchers from The ...
A recent study published in Engineering has unveiled a novel approach to generating functional organoids from human adult adipose tissue. This method, which bypasses traditional stem cell isolation and genetic manipulation, offers a more straightforward and scalable pathway for creating organoids that can be used in regenerative medicine and disease modeling.
The research, led by a team from the Shanghai Jiao Tong University School of Medicine and the Shanghai Institute for Plastic and Reconstructive Surgery, demonstrates the potential of human adult adipose tissue to differentiate into organoids representing all ...
Beijing’s metro system could soon carry express parcels alongside commuters during quiet periods, according to a new operational blueprint published in Engineering. Researchers from Beijing Jiaotong University and East China Jiaotong University have designed a joint optimization model that simultaneously plans train timetables, rolling-stock circulation, and cargo loading while allowing trains to skip stations with low demand. The approach, tested on the Yizhuang Line, cut operating costs by up to 25% compared with conventional fixed-composition, all-stop services.
The study addresses the rapid rise in urban freight volumes—already 15 million parcels a day in Beijing—by ...
Eye tumors are difficult to treat because drugs often struggle to reach tumor tissue without damaging healthy structures of the eye. A new review published in Biofunctional Materials summarizes how nanomaterials—extremely small, engineered particles—could improve both the diagnosis and treatment of eye cancers. The authors highlight recent advances, key challenges, and future directions for using nanotechnology to achieve safer and more precise eye tumor care.
Treating tumors inside the eye presents unique challenges. The eye is a small and highly sensitive organ, protected by biological barriers that limit drug penetration. While ...
Perovskite solar cells have garnered widespread attention as a low-cost, high-efficiency alternative to conventional silicon photovoltaics. However, defects in perovskite films impede charge transport, resulting in energy loss and compromised operational stability.
One solution to this problem is "passivation treatment"—a process that adds chemicals such as simple salts or organic molecules to the film. These small molecules or ions latch onto defects in the perovskite material, preventing the defects from interfering with electrical flow. Unfortunately, verifying the internal efficacyof various passivation ...
